UAE Left Ventricular Assist Devices (LVADs) Market Overview and Insights:

UAE Left Ventricular Assist Devices (LVADs) Market research is an ongoing process. Consistent monitoring and evaluating of market dynamics to stay informed and adapt your strategies accordingly. As a market research and consulting firm, we offer market research reports that focus on major parameters including Target Market Identification, Customer Needs and Preferences, Thorough Competitor Analysis, Market Size & Market Analysis, and other major factors. At the end, we do provide meaningful insights and actionable recommendations that inform decision-making and strategy development.

What is the Future Market Size of the UAE Left Ventricular Assist Devices (LVADs) Industry and its Yearly Growth Rate?

The UAE Left Ventricular Assist Devices (LVADs) Market size was valued at around USD 391.29 million in 2024 and is projected to reach USD 511.22 million by 2030. Along with this, the market is estimated to grow at a CAGR of around 4.45% during the forecast period, i.e., 2025-30. Numerous significant factors are driving the market for left ventricular assist devices in the United Arab Emirates. The various healthcare initiatives started by the UAE government with the goal of improving cardiovascular care and creating an environment that is favorable for the use of LVAD are a major source of motivation.

Request for a Free PDF Sample of the Report – https://www.marknteladvisors.com/query/request-sample/uae-lvads-market.html

Who are the Main Competitors Driving the UAE Left Ventricular Assist Devices (LVADs) Market Forward?

The prominent players essentially operating in the UAE Left Ventricular Assist Devices (LVADs) Market are as follows:

• Abbott Laboratories
• Cadrenal Therapeutics
• Fresenius Medical Care AG & Co. KGaA
• Abiomed Inc.
• Teleflex Incorporated
• SynCardia Systems
• CardiacAssist, Inc.
• Jarvik 2000
• Reliant Heart
• Edwards Lifesciences
• GE Healthcare
• Others

What are the key Drivers Defining the UAE Left Ventricular Assist Devices (LVADs) Market Size?

Increasing Prevalence of Heart Failure in the UAE – Increasing heart failure rate is the primary factor driving the growth of the left ventricular assist device market in the United Arab Emirates. Coronary heart disease leads to maximum deaths in UAE with 40% of all fatalities attributed to cardiovascular diseases in this country as per the Ministry of Health and Prevention. Since Heart failure is common in the aged population, hence modern treatments like LVADs are required. By the end of 2050, there is a probability of 2 million people in the United Arab Emirates to be 60 years of age or older. It is expected that this demographic shift will similarly increase demand for LVADs as heart failure will become more frequent in older adults. Similarly contributing to the rising prevalence of coronary heart failure are lifestyle factors including obesity rates that surpass 28% and the roughly 50% of individuals being overweight. The need for LVADs is similarly increased by a sedentary lifestyle that increases heart-related troubles.

Full Market Research Report – https://www.marknteladvisors.com/research-library/uae-lvads-market.html

What is the Segmentation of the UAE Left Ventricular Assist Devices (LVADs) Market?

The UAE Left Ventricular Assist Devices (LVADs) market covered in this report is segmented –

• By Type of Flow
  • Pulsatile Flow - Market Size & Forecast 2020-2030, USD Million
  • Non-Pulsatile Flow - Market Size & Forecast 2020-2030, USD Million
• By Design
  • Implantable Ventricular Assist Devices - Market Size & Forecast 2020-2030, USD Million
  • Transcutaneous Ventricular Assist Devices - Market Size & Forecast 2020-2030, USD Million
• By Application
  • Bridge to Transplantation - Market Size & Forecast 2020-2030, USD Million
  • Destination Therapy - Market Size & Forecast 2020-2030, USD Million
  • Bridge to Recovery - Market Size & Forecast 2020-2030, USD Million
  • Bridge to Candidacy - Market Size & Forecast 2020-2030, USD Million

The Bridge to Transplantation segment is the leading application in the UAE LVADs market holding up to 75% of the market share.

• By Region
  • Dubai
  • Abu Dhabi
  • Sharjah
  • Northern Emirates

Key Questions Answered in the Research Report

1. What is the predicted UAE Left Ventricular Assist Devices (LVADs) market size and growth rate for the years 2025-30?
2. What challenges are restricting the growth of the UAE Left Ventricular Assist Devices (LVADs) market?
3. Which segment accounted for the largest market share in the UAE Left Ventricular Assist Devices (LVADs) market?
4. Which prominent companies are leading growth in the UAE Left Ventricular Assist Devices (LVADs) market?
5. In what formats does Markntel Advisors deliver the concerned report descriptions?
6. How long does it take for customers to receive the reports provided by Markntel Advisors?
7. Does Markntel Advisors provide customized reports?

Ask Analyst for Customization and Browse full report with TOC List of Figure: https://www.marknteladvisors.com/query/request-customization/uae-lvads-market.html

Read More:

• https://reporttok.blogspot.com/2025/01/in-depth-distributed-antenna-system-das.html
• https://reporttok.blogspot.com/2025/01/comprehensive-overview-of-automated_30.html
• https://reporttok.blogspot.com/2025/01/in-depth-cancer-pain-management-market.html
• https://reporttok.blogspot.com/2025/01/saudi-arabia-plastic-packaging-industry.html
• https://reporttok.blogspot.com/2025/01/comprehensive-overview-of-data.html

For Further Queries:

Contact Us:  

MarkNtel Advisors

Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511

Address Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India

Email: sales@marknteladvisors.com

Tel No: +1 628 895 8081, +91 120 4278433